Literature DB >> 20105454

Apolipoprotein E genotype and oxidative stress response to traumatic brain injury.

S Ferguson1, B Mouzon, G Kayihan, M Wood, F Poon, S Doore, V Mathura, J Humphrey, B O'Steen, R Hayes, A Roses, M Mullan, F Crawford.   

Abstract

Traumatic Brain Injury (TBI) is known to result in oxidative stress, and as variation at the Apolipoprotein E (APOE) gene has been shown to influence outcome following TBI, but through as yet unclear mechanisms, we used transgenic APOE mouse models to examine the relationship between APOE genotype and oxidative stress following TBI. We administered a controlled cortical impact (CCI) injury or sham injury to transgenic mice expressing either human APOE3 or APOE4 on a murine APOE-deficient background. RNA was prepared from the ipsilateral hippocampi and cortices retrieved at 24 h and 1 month post-TBI. Microarray analysis was performed on unpooled samples from three mice per group to determine the genomic response to TBI and to specifically investigate the response of genes involved in oxidative stress mechanisms. Our data demonstrated TBI-induced expression of many more anti-oxidant related genes in the APOE3 mice, suggesting a potential anti-oxidative role for ApoE3 compared to ApoE4. However, in an additional cohort of mice we isolated the ipsilateral hippocampi, cortices, and cerebella at 1 month after TBI or sham injury for immunohistochemical analysis of markers of oxidative stress: the formation and presence of carbonyls (indication of general oxidative modification), 3-nitrotyrosine (3NT; specific to protein modification), or 4-hydroxyl-2-nonenal (HNE; specific to lipid peroxidation). Although we observed significant increases in all three markers of oxidative stress in response to injury, and genotype was a significant factor for carbonyl and 3NT, we found no significant interaction between genotype and injury. This may be due to the overwhelming effect of injury compared to genotype in our ANOVA, but nonetheless suggests that an influence on oxidative stress response is not the primary mechanism behind the APOE-genotype dependent effects on outcome following TBI. Copyright 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20105454     DOI: 10.1016/j.neuroscience.2010.01.031

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

Review 1.  Animal models of traumatic brain injury.

Authors:  Victoria E Johnson; David F Meaney; D Kacy Cullen; Douglas H Smith
Journal:  Handb Clin Neurol       Date:  2015

2.  COG1410, an apolipoprotein E-based peptide, improves cognitive performance and reduces cortical loss following moderate fluid percussion injury in the rat.

Authors:  Nicholas A Kaufman; Jason E Beare; Arlene A Tan; Michael P Vitek; Suzanne E McKenna; Michael R Hoane
Journal:  Behav Brain Res       Date:  2010-06-19       Impact factor: 3.332

3.  Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Authors:  L Chouliaras; A S R Sierksma; G Kenis; J Prickaerts; M A M Lemmens; I Brasnjevic; E L van Donkelaar; P Martinez-Martinez; M Losen; M H De Baets; N Kholod; F van Leeuwen; P R Hof; J van Os; H W M Steinbusch; D L A van den Hove; B P F Rutten
Journal:  Int J Alzheimers Dis       Date:  2010-10-05

4.  Naturally occurring variation in the Glutathione-S-Transferase 4 gene determines neurodegeneration after traumatic brain injury.

Authors:  Faiez Al Nimer; Mikael Ström; Rickard Lindblom; Shahin Aeinehband; Bo-Michael Bellander; Jens R Nyengaard; Olle Lidman; Fredrik Piehl
Journal:  Antioxid Redox Signal       Date:  2012-09-24       Impact factor: 8.401

5.  Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury.

Authors:  Aric F Logsdon; Brandon P Lucke-Wold; Linda Nguyen; Rae R Matsumoto; Ryan C Turner; Charles L Rosen; Jason D Huber
Journal:  Brain Res       Date:  2016-04-27       Impact factor: 3.252

6.  Apolipoprotein E Exerts a Whole-Brain Protective Property by Promoting M1? Microglia Quiescence After Experimental Subarachnoid Hemorrhage in Mice.

Authors:  Jinwei Pang; Jianhua Peng; Nathanael Matei; Ping Yang; Li Kuai; Yue Wu; Ligang Chen; Michael P Vitek; Fengqiao Li; Xiaochuan Sun; John H Zhang; Yong Jiang
Journal:  Transl Stroke Res       Date:  2018-09-17       Impact factor: 6.829

Review 7.  Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer's Disease Risk Factor APOE.

Authors:  Harvey R Fernandez; Ashima Varma; Sarah A Flowers; George William Rebeck
Journal:  Cancers (Basel)       Date:  2020-12-19       Impact factor: 6.639

8.  Apolipoprotein E ε4 allele and malondialdehyde level are independent risk factors for Alzheimer's disease.

Authors:  Natividad López-Riquelme; Jordi Alom-Poveda; Nuria Viciano-Morote; Isabel Llinares-Ibor; Consuelo Tormo-Díaz
Journal:  SAGE Open Med       Date:  2016-01-22

9.  APOE4 genetic polymorphism results in impaired recovery in a repeated mild traumatic brain injury model and treatment with Bryostatin-1 improves outcomes.

Authors:  Anna O Giarratana; Cynthia Zheng; Sahithi Reddi; Shavonne L Teng; David Berger; Derek Adler; Patrick Sullivan; Smita Thakker-Varia; Janet Alder
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.